MeSH D007889 - leiomyoma
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Johnson & Johnson | Leuprolide | Viadur |  | 2000-03-03 |  |  |
| Sandoz | Leuprolide | Leuprolide |  | 1998-08-04 |  |  |
| AbbVie | Leuprolide, Norethindrone | Lupaneta Pack |  | 2012-12-14 |  |  |
| Leuprolide | Lupron |  | 1985-04-09 | $783 M | Y2021 | |
| Leuprolide | Lupron Depot |  | 1989-01-26 |  |  | |
| Leuprolide | Lupron Depot-ped | 2028-03-22 | 1993-04-16 |  |  | |
| Sanofi | Leuprolide | Leuprolide |  | 2001-11-29 |  |  |
| Sun Pharmaceutical Industries | Leuprolide | Leuprolide |  | 2009-03-09 |  |  |
| Amneal Pharmaceuticals | Leuprolide | Leuprolide |  | 2022-10-28 |  |  |
| Accord Healthcare | Leuprolide | Camcevi | 2027-01-16 | 2021-05-25 |  |  |
| Tolmar | Leuprolide | Eligard | 2041-12-22 | 2002-01-23 |  |  |
| Leuprolide | Fensolvi | 2023-10-15 | 2020-05-01 |  |  | |
| Eugia Pharma Specialties | Leuprolide | Leuprolide |  | 2022-06-06 |  |  |
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
64%7/11
Phase 2
76%16/21
Phase 3
73%19/26
Approved: 5Overall Success rate: 35%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use